Ultrasound Historical Financial Summary

Pharmaceutical Diagnostics at a Glance Products used in over 100M-a) patient procedures Equivalent to 3 patient procedures every second Source: GE HealthCare Estimates (a For the year 2021 (b Estimated for the period 2022-2025 (c - Current Good Manufacturing Practices $2,018M-a) Revenue 34.3%-a) Segment EBIT Margin $10B-a) Global End Markets Industry CAGR of ~4-5%b) 7 CGMP-C) Manufacturing Sites (GE HealthCare O Only imaging provider that also manufactures diagnostic pharmaceuticals 8 Pre-clinical or clinical pipeline assets 20+ Brands © 2022, General Electric Company. Proprietary information. All rights reserved. 71

View entire presentation